How should I approach the management of dermatomyositis in a patient with associated malignancy?

The management of dermatomyositis in a patient with an associated malignancy requires a dual approach, focusing on both the myositis and the underlying cancer Selva-O'Callaghan et al. 2022. A crucial aspect of this management is the identification and treatment of the associated malignancy, as addressing the cancer can often lead to an improvement in the dermatomyositis symptoms Selva-O'Callaghan et al. 2022. Therefore, general principles for the recognition and referral of suspected cancer should be followed to ensure timely diagnosis of the underlying malignancy NICE NG12. If metastatic malignant disease is present, its management should adhere to established guidelines NICE CG104. Alongside cancer treatment, immunosuppressive therapies are typically employed to manage the symptoms of dermatomyositis itself Selva-O'Callaghan et al. 2022.